CMD-OPT model enables the discovery of a potent and selective RIPK2 inhibitor as preclinical candidate for the treatment of acute liver injury

Acute liver injury (ALI) serves as a critical precursor and major etiological factor in the progression and ultimate manifestation of various hepatic disorders. The prevention and treatment of ALI is still a serious global challenge. Given the limited therapeutic options for ALI, exploring novel tar...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yong Chen, Xue Yuan, Wei Yan, Yurong Zou, Haoche Wei, Yuhan Wei, Minghai Tang, Yulian Chen, Ziyan Ma, Tao Yang, Kongjun Liu, Baojian Xiong, Xiuying Hu, Jianhong Yang, Lijuan Chen
Format:	Article
Language:	English
Published:	Elsevier 2025-07-01
Series:	Acta Pharmaceutica Sinica B
Subjects:	CMD-OPT Acute liver injury RIPK2 inhibitors Anti-inflammatory Drug discovery Co-crystal
Online Access:	http://www.sciencedirect.com/science/article/pii/S2211383525003090
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

CMD-OPT model enables the discovery of a potent and selective RIPK2 inhibitor as preclinical candidate for the treatment of acute liver injury

Similar Items